Synopsis Johnson and Johnson (J&J), however, denied any plans to conduct local trials as India has relaxed regulatory requirements for imported vaccines, and said it’s in talks with the government to bring its vaccine to the country. AFP Johnson and Johnson has approached India’s drug regulatory authority seeking an approval to undertake local trials for its single-shot Covid-19 vaccine, two people aware of the development told ET. The subject expert committee (SEC) of Central Drugs Standards Control Organisation, which advises the drug regulator on applications seeking approval for vaccines, new drugs and clinical trials, will soon take up the US pharma major’s application, they said.